(Q44571321)

English

Prolonged treatment with glycerophosphocholine, an acetylcholine precursor, does not disclose the potentiating effect of cholinesterase inhibitors on GHRH-induced somatotroph secretion in anorexia nervosa

scientific article published in June 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Prolonged treatment with glycerophosphocholine, an acetylcholine precursor, does not disclose the potentiating effect of cholinesterase inhibitors on GHRH-induced somatotroph secretion in anorexia nervosa (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

anorexia nervosa

0 references

Valeria Mondelli

4

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

author name string

S Fassino

1

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

F Lanfranco

2

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

G Abbate Daga

3

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

S Destefanis

5

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

G G Rovera

6

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

F Camanni

7

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

E Ghigo

8

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

E Arvat

9

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

L Gianotti

10

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

publication date

1 June 2003

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Journal of Endocrinological Investigation

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

26

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

503-507

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

https://scigraph.springernature.com/pub.10.1007/bf03345211

0 references

Growth hormone neuroregulation and its alterations in disease states

1 reference

https://api.crossref.org/works/10.1007%2FBF03345211

21 January 2018

GH/IGF-I axis in anorexia nervosa

1 reference

https://api.crossref.org/works/10.1007%2FBF03345211

21 January 2018

Acquired growth hormone resistance

1 reference

https://api.crossref.org/works/10.1007%2FBF03345211

21 January 2018

Differential effects of feeding on the ultradian variation of the growth hormone (GH) response to GH-releasing hormone in normal subjects and patients with obesity and anorexia nervosa.

1 reference

https://api.crossref.org/works/10.1007%2FBF03345211

21 January 2018

Alpha 2-adrenoceptor sensitivity in anorexia nervosa: GH response to clonidine or GHRH stimulation

1 reference

https://api.crossref.org/works/10.1007%2FBF03345211

21 January 2018

Effect of cholinergic muscarinic receptor blockade on human growth hormone (GH)-releasing hormone-(1-44)-induced GH secretion in anorexia nervosa.

1 reference

https://api.crossref.org/works/10.1007%2FBF03345211

21 January 2018

Blockade of cholinergic muscarinic receptors by pirenzepine and GHRH-induced GH secretion in the acute and recovery phase of anorexia nervosa and atypical eating disorders.

1 reference

https://api.crossref.org/works/10.1007%2FBF03345211

21 January 2018

Involvement of brain catecholamines and acetylcholine in growth hormone hypersecretory states. Pathophysiological, diagnostic and therapeutic implications

1 reference

https://api.crossref.org/works/10.1007%2FBF03345211

21 January 2018

Effects of beta-adrenergic agonists and antagonists on the growth hormone response to growth hormone-releasing hormone in anorexia nervosa.

1 reference

https://api.crossref.org/works/10.1007%2FBF03345211

21 January 2018

Atropine blockade of growth hormone (GH)-releasing hormone-induced GH secretion in man is not exerted at pituitary level

1 reference

https://api.crossref.org/works/10.1007%2FBF03345211

21 January 2018

GH feedback occurs through modulation of hypothalamic somatostatin under cholinergic control: studies with pyridostigmine and GHRH.

1 reference

https://api.crossref.org/works/10.1007%2FBF03345211

21 January 2018

Arginine stimulates growth hormone secretion by suppressing endogenous somatostatin secretion

1 reference

https://api.crossref.org/works/10.1007%2FBF03345211

21 January 2018

Treatment of cognitive dysfunction associated with Alzheimer's disease with cholinergic precursors. Ineffective treatments or inappropriate approaches?

1 reference

https://api.crossref.org/works/10.1007%2FBF03345211

21 January 2018

Cholinergic agonist and antagonist drugs modulate the growth hormone response to growth hormone-releasing hormone in the rat: evidence for mediation by somatostatin.

1 reference

https://api.crossref.org/works/10.1007%2FBF03345211

21 January 2018

CSF neurochemistry of women with anorexia nervosa and normal women

1 reference

https://api.crossref.org/works/10.1007%2FBF03345211

21 January 2018

Proton magnetic resonance spectroscopy in acute, juvenile anorexia nervosa

1 reference

https://api.crossref.org/works/10.1007%2FBF03345211

21 January 2018

Effect of central cholinergic neurotransmission enhancement by pyridostigmine on the growth hormone secretion elicited by clonidine, arginine, or hypoglycemia in normal and obese subjects

1 reference

https://api.crossref.org/works/10.1007%2FBF03345211

21 January 2018

Brain hypometabolism of glucose in anorexia nervosa: normalization after weight gain

1 reference

https://api.crossref.org/works/10.1007%2FBF03345211

21 January 2018

Brain glucose metabolism in eating disorders assessed by positron emission tomography.

1 reference

https://api.crossref.org/works/10.1007%2FBF03345211

21 January 2018

Effects of gonadal hormone replacement on measures of basal forebrain cholinergic function

1 reference

https://api.crossref.org/works/10.1007%2FBF03345211

21 January 2018

Brain hypometabolism of glucose in anorexia nervosa: A PET scan study

1 reference

https://api.crossref.org/works/10.1007%2FBF03345211

21 January 2018

Arginine but not pyridostigmine, a cholinesterase inhibitor, enhances the GHRH-induced GH rise in patients with anorexia nervosa

1 reference

https://pubmed.ncbi.nlm.nih.gov/12952362

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Blockade of hp-GRF-40-induced GH release in normal men by a cholinergic muscarinic antagonist

1 reference

https://pubmed.ncbi.nlm.nih.gov/12952362

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of recombinant human insulin-like growth factor I administration on spontaneous and growth hormone (GH)-releasing hormone-stimulated GH secretion in anorexia nervosa

1 reference

https://pubmed.ncbi.nlm.nih.gov/12952362

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A review of endocrine changes in anorexia nervosa.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12952362

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The cholinergic hypothesis of geriatric memory dysfunction

1 reference

https://pubmed.ncbi.nlm.nih.gov/12952362

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cholinergic Blockade and Growth Hormone Responsiveness to Insulin Hypoglycemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/12952362

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Involvement of the somatostatin and cholinergic systems in the mechanism of growth hormone autofeedback regulation in the rat

1 reference

https://pubmed.ncbi.nlm.nih.gov/12952362

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduced sensitivity to pirenzepine-induced blockade of growth hormone responses to arginine, exercise, and growth hormone-releasing hormone in type I diabetic subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/12952362

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Potentiation of cholinergic tone by pyridostigmine bromide re-instates and potentiates the growth hormone responsiveness to intermittent administration of growth hormone-releasing factor in man

1 reference

https://pubmed.ncbi.nlm.nih.gov/12952362

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hypothalamic-pituitary function in anorexia nervosa

1 reference

https://pubmed.ncbi.nlm.nih.gov/12952362

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of direct and indirect acetylcholine receptor agonists on growth hormone secretion in humans

1 reference

https://pubmed.ncbi.nlm.nih.gov/12952362

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acetylcholine Inhibits the Release of Somatostatin from Rat Hypothalamus in Vitro*

1 reference

https://pubmed.ncbi.nlm.nih.gov/12952362

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF03345211

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44571321&oldid=2028454963"